PureFunds ETFx HealthTech ETF
IMED
IMED was delisted on the 6th of September, 2017.
2 hedge funds and large institutions have $915K invested in PureFunds ETFx HealthTech ETF in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
64% less capital invested
Capital invested by funds: $2.56M → $915K (-$1.65M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$818 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$1.46M |
IMED Hedge Fund Activity: Q4 2016 in Review
2 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PureFunds ETFx HealthTech ETF (IMED) for Q4 2016, worth a combined $915K — down 64% from $2.56M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new IMED positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $818. The largest seller was Virtu KCG Holdings, cutting an estimated $1.46M.
- 2 institutional investors held PureFunds ETFx HealthTech ETF (IMED) as of Q4 2016, up from 1 in Q3 2016.
- Funds reported $915K of PureFunds ETFx HealthTech ETF stock for Q4 2016, down 64% quarter-over-quarter.
- 1 fund opened new PureFunds ETFx HealthTech ETF positions in Q4 2016 and 0 closed out, a net change of +1 holder.
- The largest PureFunds ETFx HealthTech ETF buyer in Q4 2016 was UBS Group, an estimated $818 added.
- The largest PureFunds ETFx HealthTech ETF seller in Q4 2016 was Virtu KCG Holdings, an estimated $1.46M sold.
Based on aggregated 13F filings for Q4 2016.